Veterans Admin 1969.
Methods | Veterans Administration Trial RCT, 2 arms, parallel (n6 LA vs SFA), up to 8 years Summary risk of bias: moderate to high |
|
Participants | Men living at the Veterans Administration Centre
CVD risk: low
Control: randomised 422, analysed 422
Intervention: randomised 424, analysed 424
Mean years in trial: control 3.7, intervention 3.7
% male: 100
Age: mean control 65.6, intervention 65.4 Age range: all 54‐88 years Smokers: intervention 283, control 279 (unknown intervention 41, control 58) Hypertension: unclear Medications taken by ≥ 50% of those in the control group: not reported Medications taken by 20%‐49% of those in the control group: not reported Medications taken by some, but < 20% of the control group: digitalis, diuretics, oestrogens, corticoids, androgens, coumarins, nicotinic acid Location: USA Ethnicity: white 90%, black 7%, Asian 1%, Hispanic 1%, other 1% |
|
Interventions | Type: diet provided (residential institution) Comparison: ↑ corn, soybean, safflower and cottonseed oils (n‐6) vs usual institutional diet Control aims: provided, total fat 40% E (whole diet provided) Intervention aims: total fat 40% E, 2/3 of SFA replaced by unsaturated fats (from corn, soybean, safflower and cottonseed oils), dietary cholesterol reduced (whole diet provided) Dose aim: 2/3 of baseline SFA is increase of ˜12%E PUFA Baseline n‐6: 4% E LA, control arm 4.8% E PUFA Compliance by biomarkers: subcutaneous 18:2 + 18:3 11.7% fat at baseline, rising to 12.8% fat in control and 34.8% fat in intervention (after "prolonged" adherence to diet). Serum TC reduced, but not statistically significantly in intervention compared to control (‐0.37 mmol/L, 95% CI ‐0.77 to 0.03). Compliance by dietary intake: unclear,checked using coloured tickets to assess dining room attendance ‐ described as 49% in intervention and 56% in controls. Laboratory analysis of the mean of over 400 weekly collections of diet provided:
Compliance by other methods: no others reported Inclusion basis: aim was to increase unsaturated fats, not total PUFA. Total PUFA not reported but LA dose 11.7% E (best estimate), > 10% increase from baseline of ˜5% E PUFA dose: 11.7% E from total PUFA (best estimate from food composition data) Duration of intervention: up to 8‐9 years |
|
Outcomes | Main trial outcomes: mortality, heart disease Dropouts: intervention 117, control 58 withdrawals over whole trial, a few participants were involved for up to 8‐9 years Available outcomes: mortality, CV mortality (sudden death, definite MI, definite stroke, angina, PAD events), cancer deaths, cancer diagnoses, stroke, non‐fatal MI, total MI, CHD deaths (fatal MI and sudden death due to CHD), CHD events (any MI or sudden death due to CHD), some data on TC, but no variance info Response to contact: attempted but no author contact established (trial published in 1969) |
|
Notes | Trial dates: recruitment 1959‐1967 Trial funding: mainly US Public Health Service, Los Angeles County Heart Assoc, Arthur Dodd Fuller Assoc, but Corn Products Co (provided Corn oil and margarine), National Soybean Processors Assoc (provided soybean oil), Pitman‐Moore Co (provided margarine), Frozen Desserts Co (imitation ice cream). All trial authors worked for academic or health institutions |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Quote: "table of random numbers used" |
Allocation concealment (selection bias) | Unclear risk | Not described |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | Institution provided diet in a masked fashion |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | Physician knowledge of allocation was assessed and found not much better than random |
Incomplete outcome data (attrition bias) All outcomes | Low risk | All followed up via Veterans Admin system |
Selective reporting (reporting bias) | Unclear risk | No protocol or trials registry entry located |
Attention bias | Low risk | Appeared equivalent, diet provided to both arms |
Compliance | Low risk | Subcutaneous 18:2 + 18:3 11.7% fat at baseline, rising to 12.8% fat in control and 34.8% fat in intervention (after "prolonged" adherence to diet). TC reduced, but not statistically significantly in intervention compared to control (‐0.37 mmol/L, 95% CI ‐0.77 to 0.03). |
Other bias | Low risk | None found |